cmd events (.xlsx)
==================

:download:`Download original .xlsx file from GitHub <https://github.com/UCL/TLOmodel/raw/master/resources/cmd/ResourceFile_cmd_events.xlsx>`

.. contents::

info
----

====  ==============================================================================================================================================
  ..  ResourceFile\_cmd\_events
====  ==============================================================================================================================================
   0  Created by Britta Jewell on 25 March 2021
   1
   2  This file reads in parameters for the onset of each event annually in the CMD module in the TLO model. Each tab represents one event modelled.
====  ==============================================================================================================================================

ever_stroke
-----------

====  =====================================================  ========  ====================================================================================================================================================================================================================================================
  ..  parameter\_name                                           value  Unnamed: 2
====  =====================================================  ========  ====================================================================================================================================================================================================================================================
   0  baseline\_annual\_probability                            0.0038
   1  rr\_male                                                 0.9
   2  rr\_0\_4                                                 0
   3  rr\_5\_9                                                 0
   4  rr\_10\_14                                               0
   5  rr\_15\_19                                               0
   6  rr\_20\_24                                               0.15
   7  rr\_25\_29                                               0.15
   8  rr\_30\_34                                               0.15
   9  rr\_35\_39                                               0.17
  10  rr\_40\_44                                               0.2
  11  rr\_45\_49                                               0.3
  12  rr\_50\_54                                               0.7
  13  rr\_55\_59                                               0.75
  14  rr\_60\_64                                               0.85
  15  rr\_65\_69                                               0.85
  16  rr\_70\_74                                               1
  17  rr\_75\_79                                               1
  18  rr\_80\_84                                               1
  19  rr\_85\_89                                               1
  20  rr\_90\_94                                               1
  21  rr\_95\_99                                               1
  22  rr\_100                                                  1
  23  rr\_urban                                                1
  24  rr\_wealth\_1                                            1
  25  rr\_wealth\_2                                            1
  26  rr\_wealth\_3                                            1
  27  rr\_wealth\_4                                            1
  28  rr\_wealth\_5                                            1
  29  rr\_bmi\_1                                               1
  30  rr\_bmi\_2                                               1
  31  rr\_bmi\_3                                               1
  32  rr\_bmi\_4                                               1
  33  rr\_bmi\_5                                               1
  34  rr\_low\_exercise                                        1.45
  35  rr\_high\_salt                                           1.35
  36  rr\_high\_sugar                                          1
  37  rr\_tobacco                                              2.09
  38  rr\_alcohol                                              1.51
  39  rr\_marital\_status\_1                                   1
  40  rr\_marital\_status\_2                                   1
  41  rr\_marital\_status\_3                                   1
  42  rr\_in\_education                                        1
  43  rr\_current\_education\_level\_1                         1
  44  rr\_current\_education\_level\_2                         1
  45  rr\_current\_education\_level\_3                         1
  46  rr\_unimproved\_sanitation                               1
  47  rr\_no\_access\_handwashing                              1
  48  rr\_no\_clean\_drinking\_water                           1
  49  rr\_wood\_burning\_stove                                 1
  50  rr\_diabetes                                             1.8
  51  rr\_hypertension                                         2.64
  52  rr\_depression                                           1.35
  53  rr\_chronic\_kidney\_disease                             1
  54  rr\_chronic\_lower\_back\_pain                           1
  55  rr\_chronic\_ischemic\_heart\_disease                    2.38
  56  rr\_cancers                                              1
  57  rr\_hiv                                                  1
  58  rr\_ever\_stroke                                       180
  59  rr\_ever\_heart\_attack                                  1
  60  rr\_diabetes\_on\_medication                             0.59    UK Prospective Diabetes Study (UKPDS) Group, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), The Lancet 1998
  61  rr\_hypertension\_on\_medication                         0.66    Neal et al., Effects of ACE inhibitors, calcium antagonists, and other blood- pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration, The Lancet 2000
  62  rr\_chronic\_kidney\_disease\_on\_medication             1
  63  rr\_chronic\_lower\_back\_pain\_on\_medication           1
  64  rr\_chronic\_ischemic\_heart\_disease\_on\_medication    0.9     Gelbenegger et al., Aspirin for primary prevention of cardiovascular disease, BMC Medicine 2019
  65  rr\_stroke\_on\_medication                               1
  66  rr\_heart\_attack\_on\_medication                        1
====  =====================================================  ========  ====================================================================================================================================================================================================================================================

ever_heart_attack
-----------------

====  =====================================================  =======  ==============================================================================================================================================================================================
  ..  parameter\_name                                          value  Unnamed: 2
====  =====================================================  =======  ==============================================================================================================================================================================================
   0  baseline\_annual\_probability                           0.0013
   1  rr\_male                                                1.5
   2  rr\_0\_4                                                0
   3  rr\_5\_9                                                0
   4  rr\_10\_14                                              0
   5  rr\_15\_19                                              0
   6  rr\_20\_24                                              0.05
   7  rr\_25\_29                                              0.05
   8  rr\_30\_34                                              0.05
   9  rr\_35\_39                                              0.05
  10  rr\_40\_44                                              0.1
  11  rr\_45\_49                                              0.1
  12  rr\_50\_54                                              0.25
  13  rr\_55\_59                                              0.25
  14  rr\_60\_64                                              0.5
  15  rr\_65\_69                                              0.6
  16  rr\_70\_74                                              0.9
  17  rr\_75\_79                                              1
  18  rr\_80\_84                                              1
  19  rr\_85\_89                                              1
  20  rr\_90\_94                                              1
  21  rr\_95\_99                                              1
  22  rr\_100                                                 1
  23  rr\_urban                                               1
  24  rr\_wealth\_1                                           1
  25  rr\_wealth\_2                                           1
  26  rr\_wealth\_3                                           1
  27  rr\_wealth\_4                                           1
  28  rr\_wealth\_5                                           1
  29  rr\_bmi\_1                                              1
  30  rr\_bmi\_2                                              1
  31  rr\_bmi\_3                                              1
  32  rr\_bmi\_4                                              1
  33  rr\_bmi\_5                                              1
  34  rr\_low\_exercise                                       1.66
  35  rr\_high\_salt                                          1.7
  36  rr\_high\_sugar                                         1
  37  rr\_tobacco                                             1
  38  rr\_alcohol                                             0.6
  39  rr\_marital\_status\_1                                  1
  40  rr\_marital\_status\_2                                  1
  41  rr\_marital\_status\_3                                  1
  42  rr\_in\_education                                       1
  43  rr\_current\_education\_level\_1                        1
  44  rr\_current\_education\_level\_2                        1
  45  rr\_current\_education\_level\_3                        1
  46  rr\_unimproved\_sanitation                              1
  47  rr\_no\_access\_handwashing                             1
  48  rr\_no\_clean\_drinking\_water                          1
  49  rr\_wood\_burning\_stove                                1
  50  rr\_diabetes                                            3
  51  rr\_hypertension                                        3
  52  rr\_depression                                          1
  53  rr\_chronic\_kidney\_disease                            1
  54  rr\_chronic\_lower\_back\_pain                          1
  55  rr\_chronic\_ischemic\_heart\_disease                   3
  56  rr\_cancers                                             1
  57  rr\_hiv                                                 1
  58  rr\_ever\_stroke                                        1
  59  rr\_ever\_heart\_attack                                 1
  60  rr\_diabetes\_on\_medication                            0.61    UK Prospective Diabetes Study (UKPDS) Group, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), The Lancet 1998
  61  rr\_hypertension\_on\_medication                        1
  62  rr\_chronic\_kidney\_disease\_on\_medication            1
  63  rr\_chronic\_lower\_back\_pain\_on\_medication          1
  64  rr\_chronic\_ischemic\_heart\_disease\_on\_medication   0.86    Gelbenegger et al., Aspirin for primary prevention of cardiovascular disease, BMC Medicine 2019
  65  rr\_stroke\_on\_medication                              1
  66  rr\_heart\_attack\_on\_medication                       1
====  =====================================================  =======  ==============================================================================================================================================================================================

